HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Steven J Chmura Selected Research
Steven J Chmura Research Topics
Disease
33
Neoplasms (Cancer)
01/2022 - 02/2003
22
Neoplasm Metastasis (Metastasis)
01/2022 - 02/2006
11
Breast Neoplasms (Breast Cancer)
12/2020 - 02/2005
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021 - 06/2010
4
Head and Neck Neoplasms (Head and Neck Cancer)
05/2006 - 02/2003
3
Brain Neoplasms (Brain Tumor)
01/2020 - 01/2014
3
Glioblastoma (Glioblastoma Multiforme)
01/2020 - 03/2012
3
Anus Neoplasms (Anal Cancer)
11/2009 - 10/2005
2
Pneumonia (Pneumonitis)
11/2022 - 01/2022
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2007 - 10/2005
1
Disease Progression
01/2022
1
Glioma (Gliomas)
12/2021
1
Anetoderma
01/2021
1
Melanoma (Melanoma, Malignant)
01/2021
1
Bites and Stings (Sting)
01/2021
1
Infections
07/2020
1
COVID-19
07/2020
1
Gliosarcoma
01/2020
1
Fatigue
01/2020
1
Neurobehavioral Manifestations
01/2020
1
Neurologic Manifestations (Neurological Manifestations)
01/2020
1
Mediastinal Diseases
01/2019
1
Merkel Cell Carcinoma
01/2019
1
Astrocytoma (Pilocytic Astrocytoma)
09/2018
1
Multiple Myeloma
11/2017
1
Noninfiltrating Intraductal Carcinoma (DCIS)
01/2017
1
Lung Neoplasms (Lung Cancer)
01/2017
1
AIDS-Related Complex (ARC)
01/2017
1
Necrosis
04/2014
1
Pituitary Neoplasms (Pituitary Adenoma)
09/2006
1
Squamous Cell Carcinoma of Head and Neck
02/2006
1
Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
12/2004
1
Primitive Neuroectodermal Tumors (PNET)
06/2004
1
Cholangiocarcinoma
06/2004
Drug/Important Bio-Agent (IBA)
5
pembrolizumab
IBA
01/2022 - 01/2018
5
Immune Checkpoint Inhibitors
IBA
10/2021 - 01/2018
4
Biological Products
IBA
01/2019 - 01/2011
4
MicroRNAs (MicroRNA)
IBA
06/2016 - 01/2011
3
Temozolomide (Temodar)
FDA Link
Generic
12/2021 - 03/2012
3
Bevacizumab (Avastin)
FDA Link
12/2021 - 04/2014
2
Nivolumab
IBA
01/2022 - 10/2021
2
Interferons
IBA
01/2021 - 01/2018
2
B7-H1 Antigen
IBA
01/2021 - 01/2019
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2020 - 04/2014
2
Contrast Media
IBA
10/2010 - 08/2010
2
Deoxyglucose (2 Deoxy D glucose)
IBA
10/2010 - 08/2010
2
Gold
IBA
10/2010 - 08/2010
1
Ipilimumab
IBA
01/2022
1
urelumab
IBA
10/2021
1
cabiralizumab
IBA
10/2021
1
Butyrates (Butyrate)
IBA
01/2021
1
Macrophage Colony-Stimulating Factor
IBA
01/2021
1
Peptides (Polypeptides)
IBA
01/2021
1
trebananib
IBA
01/2020
1
Memantine (Namenda)
FDA Link
01/2020
1
Interferon-gamma (Interferon, gamma)
IBA
01/2019
1
Ligands
IBA
01/2019
1
Proteins (Proteins, Gene)
FDA Link
01/2019
1
Blocking Antibodies
IBA
01/2019
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
09/2018
1
DNA (Deoxyribonucleic Acid)
IBA
01/2018
1
Neoplasm Antigens (Tumor Antigens)
IBA
01/2018
1
Cytokines
IBA
01/2018
1
Silver
IBA
05/2017
1
veliparib
IBA
01/2016
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2016
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
01/2016
1
Monoclonal Antibodies
IBA
04/2014
1
bistratene A
IBA
06/2010
1
Actins (F Actin)
IBA
06/2010
1
phytobacteriomycin (PBM)
IBA
04/2008
1
Ifosfamide
FDA Link
Generic
06/2004
1
Etoposide (VP 16)
FDA Link
Generic
06/2004
Therapy/Procedure
35
Radiotherapy
11/2022 - 10/2005
25
Therapeutics
01/2022 - 12/2004
9
Drug Therapy (Chemotherapy)
01/2019 - 12/2004
5
Immunotherapy
11/2022 - 01/2019
4
Re-Irradiation
12/2021 - 02/2003
4
Segmental Mastectomy (Lumpectomy)
01/2017 - 02/2005
2
Image-Guided Radiotherapy
10/2013 - 02/2012
2
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
04/2008 - 06/2004
1
Drug Tapering
01/2022
1
Salvage Therapy
12/2021
1
Particle Accelerators
03/2021
1
Radioimmunotherapy
01/2021
1
Conformal Radiotherapy
12/2020
1
Aftercare (After-Treatment)
11/2018
1
Craniospinal Irradiation
11/2017
1
Proton Therapy
11/2017
1
Animal Assisted Therapy
12/2012
1
Chemoradiotherapy
04/2008
1
Overlapping Surgery
02/2006
1
Mastectomy (Mammectomy)
02/2005